Jubilant Pharmova Ltd (JUBLPHARMA) – Company Profile and SWOT Analysis

Jubilant Pharmova Ltd (JUBLPHARMA) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Jubilant Pharmova Ltd (Jubilant) is an integrated pharmaceutical company. The company manufactures and supplies active pharmaceutical ingredients (APIs), solid dosage formulations, allergy therapy products and radiopharmaceuticals. Jubilant offers contract manufacturing services for sterile injectables and non-sterile products and drug discovery services. The company is also engaged in the fields of oncology and autoimmune diseases. The company provides its products and services to customers across the US, India, South Africa, Canada, Singapore, Belgium and China. It owns and operates cGMP-compliant manufacturing facilities, and research and development centers in India, the US and Canada. Jubilant is headquartered in Noida, Uttar Pradesh, India.

Scope

• Detailed information on Jubilant Pharmova Ltd required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Jubilant Pharmova Ltd in the form of a SWOT analysis

• An in-depth view of the business model of Jubilant Pharmova Ltd including a breakdown and examination of key business segments

• News about Jubilant Pharmova Ltd, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Jubilant Pharmova Ltd and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Jubilant Pharmova Ltd as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Jubilant Pharmova Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

BASF India Ltd

Tata Chemicals Ltd

Teva Pharmaceutical Industries Ltd

Hetero Drugs Ltd

Dr. Reddy's Laboratories Ltd

Divi's Laboratories Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Jubilant Pharmova Ltd - Key Facts

Jubilant Pharmova Ltd - Key Employees

Jubilant Pharmova Ltd - Key Employee Biographies

Jubilant Pharmova Ltd - Major Products and Services

Jubilant Pharmova Ltd - History

Jubilant Pharmova Ltd - Company Statement

Jubilant Pharmova Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Jubilant Pharmova Ltd - Business Description

Business Segment: Allergy Immunotherapy

Overview

Performance

Business Segment: Contract Development and Manufacturing Organisation - Sterile Injectables

Overview

Performance

Business Segment: Contract Research, Development and Manufacturing Organisation

Overview

Performance

Business Segment: Generics

Overview

Performance

Business Segment: Proprietary Novel Drugs

Overview

Performance

Business Segment: Radiopharma

Overview

Performance

Geographical Segment: Americas and Europe

Performance

Geographical Segment: India

Performance

Geographical Segment: Rest of the World

Performance

R&D Overview

Jubilant Pharmova Ltd - Corporate Strategy

Jubilant Pharmova Ltd - SWOT Analysis

SWOT Analysis - Overview

Jubilant Pharmova Ltd - Strengths

Jubilant Pharmova Ltd - Weaknesses

Jubilant Pharmova Ltd - Opportunities

Jubilant Pharmova Ltd - Threats

Jubilant Pharmova Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances

Jubilant Pharmova Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

Jubilant Pharmova Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024

Jubilant Pharmova Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jun 18, 2024: Jubilant Pharmova Announces Completion of USFDA Audit of Contract Manufacturing Facility at Montreal, Canada

May 02, 2024: Jubilant Pharmova Announces Appointment of Radiopharma Business

Apr 18, 2024: Jubilant Pharmova Closure of Manufacturing Operations of Solid Dosage Formulation Facility of Jubilant Cadista Pharmaceuticals Inc., USA

Apr 17, 2024: USFDA determines inspection classification of ‘Voluntary Action Indicated’ for the Solid dosage manufacturing facility at Roorkee, India

Feb 02, 2024: Jubilant Pharmova Reports Unaudited Financial Results for the Quarter and Nine Months Ended December 31, 2023

May 30, 2023: Jubilant Pharmova Announces Resignation of CFO, Mr. Arun K Sharma

May 30, 2023: Jubilant Pharmova Announces Appointment of Joint Managing Director

May 30, 2023: Jubilant Pharmova Announces Resignation of Managing Director

May 29, 2023: Jubilant Pharmova Announces Audited Results For The Quarter And Year Ended March 2023

May 29, 2023: Jubilant Pharmova : USFDA inspection update – Contract manufacturing facility at Montreal Canada

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Jubilant Pharmova Ltd, Key Facts

Jubilant Pharmova Ltd, Key Employees

Jubilant Pharmova Ltd, Key Employee Biographies

Jubilant Pharmova Ltd, Major Products and Services

Jubilant Pharmova Ltd, History

Jubilant Pharmova Ltd, Subsidiaries

Jubilant Pharmova Ltd, Key Competitors

Jubilant Pharmova Ltd, Ratios based on current share price

Jubilant Pharmova Ltd, Annual Ratios

Jubilant Pharmova Ltd, Annual Ratios (Cont…1)

Jubilant Pharmova Ltd, Annual Ratios (Cont…2)

Jubilant Pharmova Ltd, Interim Ratios

Jubilant Pharmova Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

Jubilant Pharmova Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024

Jubilant Pharmova Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Jubilant Pharmova Ltd, Performance Chart (2020 – 2024)

Jubilant Pharmova Ltd, Ratio Charts

Jubilant Pharmova Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

Jubilant Pharmova Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports